Half Yearly Report

Assets

Amount

Liabilities & Shareholders Equity

Amount

Cash

2,326,911

1,866,771

Financial assets at fair value through profit or loss-current

-

Long-term Liabilities

1,429,583

Available-for-sale financial assets-current

314,895

Other Liabilities

190,523

Accounts & Notes receivable

505,873

Total Liabilities

3,486,877

Other Receivable

272,454

Inventories

1,173,602

Capital stock

5,969,099

Deferred income tax-current

4,239

Shares to be issued

-

Other current assets

65,808

Capital surplus

1,734,049

Total Current Assets

4,663,782

Appropriated as legal reserve

2,426,181

Appropriated as special reserve

191,229

Total Long-term Investments

6,585,645

Unappropriated earnings (deficit)

(145,247)

Unrealized gain on investments

(971,148)

Net Properties

817,229

Cumulative translation adjustment

66,308

Intangible Assets-Net

241,061

Treasury Stock

(155,236)

Total Other Assets

294,395

Total Shareholders Equity

9,115,235

Total Assets

12,602,112

Total Liabilities & Shareholders' Equity

12,602,112

ITEM

2012*

2011

YoY % (decline)

Net Sales

1,599,184

2,068,574

(22.7)%

Realized (unrealized) inter-company profit-net

0

4,800

(100.0)%

Cost of Sales

1,011,138

1,423,781

(29.0)%

Gross Profit

588,046

649,593

(9.5)%

Operating Expenses

769,710

766,715

0.4%

Income from Operations(Loss)

(181,664)

(117,122)

55.1%

Non-Operating Income

62,783

232,176

(73.0)%

Non-Operating Expenses

26,366

172,068

(84.7)%

Income before Income Tax(Loss)

(145,247)

(57,014)

154.8%

Income Tax Benefit (Expenses)

0

(36,836)

(100.0)%

Net Income(Loss)

(145,247)

(93,850)

54.8%

Earnings per share**

(0.25)

(0.16)

ITEM

2012*

2011

Cash Flow in (out) from operating

(300,973)

451,448

Cash Flow in (out) from Investing

(236,185)

(102,952)

Cash Flow in (out) from Financing

1,058,365

(315,206)

Net Increase (Decrease) in Cash & Cash Equivalents

521,207

33,290

Cash & Cash Equivalents, Beginning of Period

1,805,704

2,097,829

Cash & Cash Equivalents, End of Period

2,326,911

2,131,119